- Home
- RCON vs EPIX Comparison
RCON vs EPIX Comparison
Compare RCON & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- EPIX
- Stock Information
- Founded
- RCON 2007
- EPIX 2009
- Country
- RCON China
- EPIX Canada
- Employees
- RCON N/A
- EPIX N/A
- Industry
- RCON Oilfield Services/Equipment
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- EPIX Health Care
- Exchange
- RCON Nasdaq
- EPIX Nasdaq
- Market Cap
- RCON 86.1M
- EPIX 75.9M
- IPO Year
- RCON 2009
- EPIX N/A
- Fundamental
- Price
- RCON $2.24
- EPIX $0.24
- Analyst Decision
- RCON
- EPIX Hold
- Analyst Count
- RCON 0
- EPIX 3
- Target Price
- RCON N/A
- EPIX $2.00
- AVG Volume (30 Days)
- RCON 176.0K
- EPIX 13.5M
- Earning Date
- RCON 09-26-2025
- EPIX 08-13-2025
- Dividend Yield
- RCON N/A
- EPIX N/A
- EPS Growth
- RCON N/A
- EPIX N/A
- EPS
- RCON N/A
- EPIX N/A
- Revenue
- RCON $8,996,572.00
- EPIX N/A
- Revenue This Year
- RCON N/A
- EPIX N/A
- Revenue Next Year
- RCON $12.17
- EPIX N/A
- P/E Ratio
- RCON N/A
- EPIX N/A
- Revenue Growth
- RCON N/A
- EPIX N/A
- 52 Week Low
- RCON $1.40
- EPIX $0.22
- 52 Week High
- RCON $7.16
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- RCON 43.35
- EPIX 5.39
- Support Level
- RCON $2.15
- EPIX $0.22
- Resistance Level
- RCON $2.44
- EPIX $1.94
- Average True Range (ATR)
- RCON 0.28
- EPIX 0.02
- MACD
- RCON -0.05
- EPIX -0.20
- Stochastic Oscillator
- RCON 19.37
- EPIX 0.86
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.